Abstract
Ten million deaths due to antimicrobial resistance are anticipated by 2050.1 As such, antimicrobial resistance is a current focus of the global medical community. With the anticipated rapid growth in deaths associated with multiresistant infections, antimicrobial stewardship programmes are expected to direct their efforts towards reducing the consumption of antimicrobials. Despite this situation, the gastroenterology community is calling for population-based programmes to eliminate Helicobacter pylori (H pylori) for the prevention of gastric cancer and other diseases related to H pylori infection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
